Latest Biotechnology Innovation News

LTR Pharma has acquired a one-third equity stake in LevOmega Pty Ltd at no cost to shareholders, positioning itself in the growing pharmaceutical-grade omega-3 sector. This strategic move complements LTR’s existing intranasal pharmaceutical portfolio and aligns with its innovation-driven growth strategy.

Starpharma has received a $3.7 million R&D Tax Incentive refund for the 2025 financial year, reinforcing its commitment to advancing dendrimer technology and biotechnology innovation in Australia.

BPH Global Ltd has raised $609,000 through a targeted placement and made significant strides in its Indonesian seaweed venture, including binding offtake agreements and R&D breakthroughs on mineral extraction.